Estimating the cost of treating patients with liver cirrhosis at the Mexican Social Security Institute

被引:0
|
作者
Esther Quiroz, Maria
Flores, Yvonne N. [1 ,2 ,3 ]
Aracena, Belkis [4 ]
Granados-Garcia, Victor [5 ]
Salmeron, Jorge
Perez, Ruth
Cabrera, Guillermo
Bastani, Roshan [2 ,3 ]
机构
[1] Inst Mexicano Seguro Social, Unidad Invest Epidemiol, Cuernavaca 62450, Morelos, Mexico
[2] UCLA Sch Publ Hlth, Los Angeles, CA USA
[3] Jonsson Comprehens Canc Ctr, Los Angeles, CA 90034 USA
[4] Inst Nacl Salud Publ, Cuernavaca, Morelos, Mexico
[5] Inst Mexicano Seguro Social, Ctr Med Nacl Siglo 21, Mexico City, DF, Mexico
来源
SALUD PUBLICA DE MEXICO | 2010年 / 52卷 / 06期
关键词
costs and cost analysis; liver cirrhosis; Mexico; HEPATOCELLULAR-CARCINOMA; DIABETES INCREASES; UNITED-STATES; HEPATITIS-C; CARE COSTS; MANAGEMENT; DISEASE; RISK; RECOMMENDATIONS; HYPERTENSION;
D O I
暂无
中图分类号
R1 [预防医学、卫生学];
学科分类号
1004 ; 120402 ;
摘要
Objective. To estimate the annual cost of treating patients with cirrhosis at the Mexican Institute of Social Security (IMSS per its abbreviation in Spanish). Material and Methods. The annual cost of treating three stages of cirrhosis (Child-Pugh A, Child-Pugh B and Child-Pugh C) was estimated using micro-costing techniques and medical experts. These results were compared and contrasted with prices reported by IMSS. Results. The annual cost of treatment, in USA dollars, by Child-Pugh stage was: a) micro-costing results: $1 110.17 stage A, $549.55 stage B and $348.16 stage C; b) opinion of medical experts: $1 633.64, $6 564.04 and $19 660.35, respectively; and c) IMSS costs: $4 269.00, $16 949.63 and $30 249.25, respectively. Conclusions. The cost of treating patients with cirrhosis is considerable, and costs increase as the disease worsens. Cost estimates vary depending on the source of information, and the methodology used. There are discrepancies between the procedures reported in medical records and treatment recommendations by IMSS liver experts.
引用
收藏
页码:493 / 501
页数:9
相关论文
共 50 条
  • [21] Cost-effectiveness of the use of the continuous subcutaneous insulin infusion pump versus daily multiple injections in type 1 diabetes adult patients at the Mexican Institute of Social Security
    Svetlana V. Doubova
    Stephane Roze
    Aldo Ferreira-Hermosillo
    Ricardo Pérez-Cuevas
    Ricardo Gasca-Pineda
    Casper Barsoe
    Jonathan Baran
    Brian Ichihara
    Erick Gryzbowski
    Kyla Jones
    Juan E. Valencia
    Cost Effectiveness and Resource Allocation, 17
  • [22] Blood lead levels in newborn children and mothers covered by the Mexican Institute of Social Security.
    Navarrete-Espinosa, J
    Sanín-Aguirre, LH
    Escandón-Romero, C
    Benítez-Martínez, G
    Olaiz-Fernández, G
    Hernández-Avila, M
    SALUD PUBLICA DE MEXICO, 2000, 42 (05): : 391 - 396
  • [23] Costs of medical care attributable to tobacco consumption at the Mexican Institute of Social Security (IMSS), Morelos
    Reynales-Shigematsu, Luz Myriam
    Juarez-Marquez, Sergio Arturo
    Valdes-Salgado, Raydel
    SALUD PUBLICA DE MEXICO, 2005, 47 (06): : 451 - 457
  • [24] Cost-effectiveness of the use of the continuous subcutaneous insulin infusion pump versus daily multiple injections in type 1 diabetes adult patients at the Mexican Institute of Social Security
    Doubova, Svetlana V.
    Roze, Stephane
    Ferreira-Hermosillo, Aldo
    Perez-Cuevas, Ricardo
    Gasca-Pineda, Ricardo
    Barsoe, Casper
    Baran, Jonathan
    Ichihara, Brian
    Gryzbowski, Erick
    Jones, Kyla
    Valencia, Juan E.
    COST EFFECTIVENESS AND RESOURCE ALLOCATION, 2019, 17 (01)
  • [25] Economic benefits of using a dose dispensing system at hospital units of the Mexican Institute of Social Security
    Ofelia-Uc Coyoc, Rocio
    Gabriela Perez-Reynaud, Ana
    Arturo Coello-Reyes, Luis
    SALUD PUBLICA DE MEXICO, 2014, 56 (03): : 272 - 278
  • [26] Research on quality of health care from the Mexican Social Security Institute. A bibliometric study
    Navarrete-Navarro, Susana
    Gomez-Delgado, Alejandro
    Riebeling-Navarro, Carlos
    Araceli Lopez-Garcia, Gloria
    Nava-Zavala, Arnulfo
    SALUD PUBLICA DE MEXICO, 2013, 55 (06): : 564 - 571
  • [27] Creatinine Versus Cystatin C for Estimating GFR in Patients With Liver Cirrhosis
    Torre, Aldo
    Manuel Aguirre-Valadez, Jonathan
    Manuel Arreola-Guerra, Jose
    Rene Garcia-Flores, Octavio
    Garcia-Juarez, Ignacio
    Cruz-Rivera, Cristino
    Correa-Rotter, Ricardo
    Antonio Nino-Cruz, Jose
    AMERICAN JOURNAL OF KIDNEY DISEASES, 2016, 67 (02) : 342 - 344
  • [28] Estimation of Health-Care Costs for Work-Related Injuries in the Mexican Institute of Social Security
    Carlos-Rivera, Fernando
    Aguilar-Madrid, Guadalupe
    Anaya Gomez-Montenegro, Pablo
    Juarez-Perez, Cuauhemoc A.
    Raul Sanchez-Roman, Francisco
    Durcudoy Montandon, Jaqueline E. A.
    Borja-Aburto, Victor Hugo
    AMERICAN JOURNAL OF INDUSTRIAL MEDICINE, 2009, 52 (03) : 195 - 201
  • [29] Demographic analysis of a congenital heart disease clinic of the Mexican Institute of Social Security, with special interest in the adult
    Marquez-Gonzalez, Horacio
    Yanez-Gutierrez, Lucelli
    Lucely Rivera-May, Jimena
    Lopez-Gallegos, Diana
    Almeida-Gutierrez, Eduardo
    ARCHIVOS DE CARDIOLOGIA DE MEXICO, 2018, 88 (05): : 360 - 368
  • [30] SARS-CoV-2 epidemic behavior in worker population affiliated to the Mexican Social Security Institute
    Hernandez-Avila, Mauricio
    Vieyra-Romero, Waldo
    Gutierrez-Diaz, Hector
    Barros-Sierra, David
    Zepeda, Rodrigo
    Segura-Sanchez, Carlos
    Velasco, Rebeca
    Alejandro Ramirez, Emmanuell
    Tamayo-Ortiz, Marcela
    Borja-Aburto, Victor
    Rascon-Pacheco, Alberto
    Barrientos-Gutierrez, Tonatiuh
    Ortega-Alvarez, Manuel
    SALUD PUBLICA DE MEXICO, 2021, 63 (05): : 607 - 618